Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 8-K, filed Aug 19, 2026
- Incorporated
- Delaware
- Filings on record
- 699 filings
- On EDGAR
- CIK 1658247
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 33
News 8 of 118
Prospectuses and Registrations 8 of 32
- S-8 Registration statement for an employee plan Feb 26, 2026
- 424B5 Prospectus supplement for an offering Jan 7, 2026
- 424B5 Prospectus supplement for an offering Jan 5, 2026
- S-8 Registration statement for an employee plan Feb 27, 2025
- 424B5 Prospectus supplement for an offering Oct 9, 2024
- 424B5 Prospectus supplement for an offering Oct 8, 2024
- 424B5 Prospectus supplement for an offering Jun 24, 2024
- S-3ASR Automatic shelf registration Jun 21, 2024
Proxies 8 of 22
- DEFM14A Jul 31, 2026
- PREM14A Jul 21, 2026
- DEFA14A Extra proxy material Jul 10, 2026
- DEFA14A Extra proxy material Jul 6, 2026
- DEFA14A Extra proxy material Jul 6, 2026
- DEFA14A Extra proxy material Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEFA14A Extra proxy material May 20, 2025
Ownership 8 of 463
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- 4 Insider reported a trade Aug 11, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 7, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 3, 2026
- 4 Insider reported a trade Jul 7, 2026
- 144 Notice of a proposed sale of restricted stock Jul 2, 2026
- 144 Notice of a proposed sale of restricted stock Jul 2, 2026
- 4 Insider reported a trade Jun 22, 2026
Other 8 of 31
- ARS Annual report sent to shareholders Apr 29, 2026
- ARS Annual report sent to shareholders Apr 23, 2025
- ARS Annual report sent to shareholders Apr 25, 2024
- D Mar 11, 2024
- ARS Annual report sent to shareholders Apr 27, 2023
- UPLOAD Comment letter from SEC staff Apr 4, 2023
- CORRESP Reply to SEC staff Mar 15, 2023
- UPLOAD Comment letter from SEC staff Feb 14, 2023
Everything here comes from Crinetics Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.